Exact Mass: 201.104811
Exact Mass Matches: 201.104811
Found 500 metabolites which its exact mass value is equals to given mass value 201.104811,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Simazine
CONFIDENCE standard compound; INTERNAL_ID 858; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8025; ORIGINAL_PRECURSOR_SCAN_NO 8021 CONFIDENCE standard compound; INTERNAL_ID 858; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8027; ORIGINAL_PRECURSOR_SCAN_NO 8026 CONFIDENCE standard compound; INTERNAL_ID 858; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7974; ORIGINAL_PRECURSOR_SCAN_NO 7973 CONFIDENCE standard compound; INTERNAL_ID 858; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8043; ORIGINAL_PRECURSOR_SCAN_NO 8040 CONFIDENCE standard compound; INTERNAL_ID 858; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7976; ORIGINAL_PRECURSOR_SCAN_NO 7974 CONFIDENCE standard compound; INTERNAL_ID 858; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8014; ORIGINAL_PRECURSOR_SCAN_NO 8012 This spectrum was originally uploaded as desethylterbutylazine and corrected to simazine upon expert review; CONFIDENCE standard compound; INTERNAL_ID 4041 CONFIDENCE standard compound; EAWAG_UCHEM_ID 262 CONFIDENCE standard compound; INTERNAL_ID 4041 CONFIDENCE standard compound; INTERNAL_ID 8419 CONFIDENCE standard compound; INTERNAL_ID 3141 D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
Carbaryl
CONFIDENCE standard compound; INTERNAL_ID 1032; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8025; ORIGINAL_PRECURSOR_SCAN_NO 8021 CONFIDENCE standard compound; INTERNAL_ID 1032; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7976; ORIGINAL_PRECURSOR_SCAN_NO 7974 CONFIDENCE standard compound; INTERNAL_ID 1032; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8014; ORIGINAL_PRECURSOR_SCAN_NO 8012 CONFIDENCE standard compound; INTERNAL_ID 1032; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8027; ORIGINAL_PRECURSOR_SCAN_NO 8026 CONFIDENCE standard compound; INTERNAL_ID 1032; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7974; ORIGINAL_PRECURSOR_SCAN_NO 7973 CONFIDENCE standard compound; INTERNAL_ID 1032; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8266; ORIGINAL_PRECURSOR_SCAN_NO 8263 D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C254 - Anti-Infective Agent > C276 - Antiparasitic Agent CONFIDENCE standard compound; INTERNAL_ID 2624 CONFIDENCE standard compound; INTERNAL_ID 8486 D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals
L-Dihydroanticapsin
An L-alanine derivative in which one of the methyl hydrogens of L-alanine is replaced by a 5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl group.
N(beta)-Fumarylcarboxyamido-2,3-diaminopropionic acid
Capryloylglycine
Capryloylglycine is an acylglycine consisting of caprylic acid (an 8-carbon medium chain fatty acid) conjugated to glycine. Acylglycines have an aliphatic acyl chain attached to the amino group of glycine through a peptide bond. Capryloylglycine is a solid with moderate solubility in water. Acylglycines are produced through the action of the enzyme glycine N-acyltransferase (EC 2.3.1.13). Acylglycines are normally minor metabolites of fatty acids. However, the excretion of certain acylglycines is increased in several inborn errors of metabolism. In certain cases, the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation, including medium-chain acyl-coenzyme A (CoA) dehydrogenase (MCAD) deficiency and multiple acyl-CoA dehydrogenation defect (MAD) (PMID: 10708405). Capryloylglycine is frequently used as a cosmetic ingredient where it functions as a conditioning agent or a surfactant. It helps protect the skin’s surface from water loss and can enhance the effectiveness of cosmetic preservatives. Capryloylglycine-containing creams have been shown to inhibit hair growth in individuals suffering from hypertrichosis (PMID: 33934471), due to it inhibiting ornithine decarboxylase 1, which is present in hair follicles. Capryloylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction:
(E)-1-Cinnamoylpyrrolidine
(E)-1-Cinnamoylpyrrolidine is found in beverages. (E)-1-Cinnamoylpyrrolidine is an alkaloid from the roots of kava (Piper methysticum). FDA advises against use of kava in food due to potential risk of severe liver damage (2002). Alkaloid from the roots of kava (Piper methysticum). FDA advises against use of kava in food due to potential risk of severe liver damage (2002). (E)-1-Cinnamoylpyrrolidine is found in beverages.
N-(5-Methyl-3-oxohexyl)alanine
N-(5-Methyl-3-oxohexyl)alanine is a constituent of false sago (Cycas circinalis) (Cycadaceae). Constituent of false sago (Cycas circinalis) (Cycadaceae)
Valproylglycine
In humans, valproylglycine has been identified as a urinary metabolite of Valproic acid (Abbott and Anari 1999) along with VPA-glutamate conjugate.Valproic acid (VPA; 2-n-propylpentanoic acid) is widely used as a major drug in the treatment of epilepsy and in the control of several types of seizures. [HMDB] In humans, valproylglycine has been identified as a urinary metabolite of Valproic acid (Abbott and Anari 1999) along with VPA-glutamate conjugate.Valproic acid (VPA; 2-n-propylpentanoic acid) is widely used as a major drug in the treatment of epilepsy and in the control of several types of seizures.
1',2'-Dihydro-1,1'-dimethyl-2'-oxo-4,4'-bipyridinium(1+)
1,2-Dihydro-1,1-dimethyl-2-oxo-4,4-bipyridinium(1+) is a metabolite of 1,1-Dimethyl-4,4-bipyridinium(2+)
2,3-Dihydro-6-methyl-5-(5-methyl-2-furanyl)-1H-pyrrolizine
Proline-derived Maillard product. Proline-derived Maillard product
N-Acetylaminooctanoic acid
N-Acetylaminooctanoic acid belongs to the family of N-acyl-alpha Amino Acids and Derivatives. These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen atom.
Dimethylguanidino valeric acid
Dimethylguanidino valeric acid or DMGV is a product formed from the transamination of asymmetric dimethylarginine (ADMA) via the enzyme alanine-glyoxylate aminotransferase 2 (AGXT2). This pathway is involved in nitric oxide regulation. DMGV has been detected in both blood and urine (PMID: 21945966 ). More recently DMGV has been identified as an independent plasma biomarker of nonalcoholic fatty liver disease (NAFLD). Furthermore, plasma DMGV levels are correlated with biopsy-proven nonalcoholic steatohepatitis (NASH). Plasma DMGV levels have also been found to decline in parallel with improvements in post-procedure cardiometabolic parameters. Plasma DMGV levels have been shown to be able to predict the development of type 2 diabetes up to 12 years before disease onset (PMID: 29083323). Baseline plasma levels of DMGV have been shown to be positively associated with body fat percentage, abdominal visceral fat, very low-density lipoprotein cholesterol (VLDL), and triglycerides. Plasma levels of DMGV are inversely associated with insulin sensitivity, low-density lipoprotein cholesterol, high-density lipoprotein size, and high-density lipoprotein cholesterol (HDL). Overall, DMGV is associated with partial resistance to metabolic health benefits of regular exercise (PMID: 31166569).
(E)-4,5-Dihydro-6-(2-(4-pyridinyl)ethenyl)-3(2H)-pyridazinone
C11H11N3O (201.09020759999999)
Misonidazole
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D011838 - Radiation-Sensitizing Agents D000970 - Antineoplastic Agents
1-Hydroxy-2,2,5,5-tetramethylpyrrolidine-3-carboxylic acid methyl ester
lepomerine
Leptomerine is a natural product found in Haplophyllum griffithianum and Esenbeckia leiocarpa with data available.
1-Cinnamoylpyrrolidine
1-Cinnamoylpyrrolidine is an olefinic compound. It is functionally related to a cinnamic acid. 1-Cinnamoylpyrrolidine is a natural product found in Piper caninum, Piper methysticum, and other organisms with data available.
Leptomerine
Leptomerine is a natural product found in Haplophyllum griffithianum and Esenbeckia leiocarpa with data available.
1,2-Dihydroxy-3-(hydroxymethyl)-5-methylindolizidine
Desethylterbuthylazine
CONFIDENCE standard compound; EAWAG_UCHEM_ID 671
AMOZ
D000890 - Anti-Infective Agents > D023303 - Oxazolidinones
9-methanesulfinylnonanenitrile (isomer of 666)
C10H19NOS (201.11872839999998)
Annotation level-3
(3-hydroxybutan-20-yl)5-oxopyrrolidine-2-carboxylate
1, 2-O-Isopropylidene, oxime-3, 6-Dideoxy-erythro-hexopyranos-4-ulose
1-(1H-indol-6-yl)-3-methylbutan-1-one|verticillatine B
CARBARYL
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C254 - Anti-Infective Agent > C276 - Antiparasitic Agent D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 3038 EAWAG_UCHEM_ID 3038; CONFIDENCE standard compound
Desethylterbutylazine
CONFIDENCE standard compound; INTERNAL_ID 2538 CONFIDENCE standard compound; INTERNAL_ID 8419
9-methanesulfinylnonanenitrile (isomer of 665)
C10H19NOS (201.11872839999998)
Annotation level-3
2-oxo-5-(3,3-Dimethylguanidine-1-yl)pentanoic acid
1-methyl-4-(1-methyl-2-oxo-1,2-dihydropyridin-4-yl)pyridin-1-ium
2,3-Dihydro-6-methyl-5-(5-methyl-2-furanyl)-1H-pyrrolizine
2-CHLORO-N-CYCLOHEX-1-EN-1-YL-N-ETHYLACETAMIDE
C10H16ClNO (201.09203559999997)
(NE)-N-[(2-methoxynaphthalen-1-yl)methylidene]hydroxylamine
CARBAMIC ACID, (2-CYCLOPROPYL-2-HYDROXYETHYL)-, 1,1-DIMETHYLETHYL ESTER
1H-Indole-3-carboxaldehyde,2-methyl-1-propyl-(9CI)
[2-(3-METHOXY-PHENYL)-ETHYL]-METHYL-AMINE HYDROCHLORIDE
C10H16ClNO (201.09203559999997)
Phenol,4-amino-5-methyl-2-(1-methylethyl)-, hydrochloride (1:1)
C10H16ClNO (201.09203559999997)
1-(2-methoxyethyl)-6-oxopiperidine-3-carboxylic acid
(+)-o-methyl-l-phenylalaninol hydrochloride
C10H16ClNO (201.09203559999997)
N-(4-Methoxyphenyl)-2-pyrazinamine
C11H11N3O (201.09020759999999)
7-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline
pseudoephedrine hydrochloride
C10H16ClNO (201.09203559999997)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents
1,2,3,4-Tetrahydrocyclopenta[b]indole-2-carboxylic acid
(R)-1-(3-Ethoxyphenyl)ethanamine hydrochloride
C10H16ClNO (201.09203559999997)
Pyridine, 2-(4-hydrazinylbutyl)-, hydrochloride (1:1)
1-(5-METHYL-1-PHENYL-1H-1,2,4-TRIAZOL-3-YL)ETHANONE
C11H11N3O (201.09020759999999)
2-AMINO-4-PHENOXY-6-METHYLPYRIMIDINE
C11H11N3O (201.09020759999999)
N-METHYL-1-(5-METHYL-2-PHENYL-3-FURYL)METHYLAMINE 95
METHYL 2-[3-(METHOXYMETHYL)-5-OXO-2-PYRROLIDINYL]ACETATE
1H-Indole-3-carboxaldehyde,2-methyl-1-(1-methylethyl)-(9CI)
(E)-2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-ylidene)ethylamine
5-(4-methoxyphenyl)pyrazin-2-amine
C11H11N3O (201.09020759999999)
3-(6-methylpyrazin-2-yl)oxyaniline
C11H11N3O (201.09020759999999)
(S)-1-tert-Butyl 2-methyl aziridine-1,2-dicarboxylate
tert-Butyl 3-(hydroxymethyl)-3-methylazetidine-1-carboxylate
(1R)-1-(4-ethoxyphenyl)ethanamine,hydrochloride
C10H16ClNO (201.09203559999997)
(S)-1-(4-Methoxyphenyl)propan-1-amine hydrochloride
C10H16ClNO (201.09203559999997)
(1S)-1-(4-ethoxyphenyl)ethanamine,hydrochloride
C10H16ClNO (201.09203559999997)
4-(dimethylamino)quinazoline-6-carbaldehyde
C11H11N3O (201.09020759999999)
2-methylquinoline-6-carbohydrazide
C11H11N3O (201.09020759999999)
2-(1H-PYRROL-1-YL)BENZENE-1-CARBOHYDRAZIDE
C11H11N3O (201.09020759999999)
Sanedrine
C10H16ClNO (201.09203559999997)
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
(S)-(+)-AMINO-2-METHYL-1-PHENYL-PROPAN-2-OL HCL
C10H16ClNO (201.09203559999997)
2-(tert-Butoxycarbonylamino)acrylic acid methyl ester
(R)-1-(4-Methoxyphenyl)propan-1-amine hydrochloride
C10H16ClNO (201.09203559999997)
1-(2-METHOXYPHENYL)PROPYLAMINE-HCl
C10H16ClNO (201.09203559999997)
1-PHENYL-5-METHYL-1H-PYRAZOLE-4-CARBOXAMIDE
C11H11N3O (201.09020759999999)
(R)-1-tert-Butyl 2-Methyl aziridine-1,2-dicarboxylate
1H-Indole-1-carbonyl chloride, octahydro-2-methyl- (9CI)
C10H16ClNO (201.09203559999997)
(2S)-1,2-PYRROLIDINEDICARBOXYLIC ACID-1-EHTYL-2-METHYL ESTER
2(1H)-Pyrimidinone,4-amino-1-(phenylmethyl)-
C11H11N3O (201.09020759999999)
(3,5-DIIODO-TYR1,D-ALA2)-MET-ENKEPHALINAMIDEACETATESALT
(1S,3R,4S,6R)-N-BOC-6-AMINO-2,2-DIMETHYLTETRAHYDROCYCLOPENTA[1.3]DIOXOLE-4-CARB ACID
1-(2,3-DIHYDRO-BENZO[1,4]DIOXINE-6-SULFONYL)-PIPERAZINE
4-carboxy-2,2,5,5-tetramethyl-3-imidazoline-3-oxide-1-oxyl, free radical
6-(4-methoxyphenyl)pyridazin-3-amine
C11H11N3O (201.09020759999999)
Edrophonium chloride
C10H16ClNO (201.09203559999997)
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D020011 - Protective Agents > D000931 - Antidotes D004791 - Enzyme Inhibitors
2-HYDROXY-N,N,N-TRIMETHYLETHANAMINIUM DIHYDROGENPHOSPHATE
TERT-BUTYL ((1R,3S)-3-HYDROXYCYCLOPENTYL)CARBAMATE
Racephedrine hydrochloride
C10H16ClNO (201.09203559999997)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
Methyl 1-(2-Methoxyethyl)-2-oxopyrrolidine-4-carboxylate
tert-butyl 3-hydroxy-3-methyl-pyrrolidine-1-carboxylate
1-(2-Cyano-phenyl)-cyclopropanecarboxylic acid Methyl ester
6-(1-chloroethyl)-2-N,2-N-dimethyl-1,3,5-triazine-2,4-diamine
5-Pyrimidinemethanol, 2-(phenylamino)- (9CI)
C11H11N3O (201.09020759999999)
2-(2-AMINOETHYL)-4(3H)-QUINAZOLINONEMONOHYDROCHLORIDE
tert-Butyl 3-(2-hydroxyethyl)azetidine-1-carboxylate
(R)-1-(tert-Butoxycarbonyl)azetidine-2-carboxylic acid
2-ISOPROPYL-4-AMINO ANISOLE HYDROCHLORIDE
C10H16ClNO (201.09203559999997)
3,4-DIHYDRO-1-ISOPROPYLISOQUINOLINE-7-CARBALDEHYDE
(S)-1-(3-Ethoxyphenyl)ethanamine hydrochloride
C10H16ClNO (201.09203559999997)
3-Pyridinamine, 6-[(2-methyl-3-pyridinyl)oxy]-
C11H11N3O (201.09020759999999)
1,3-dihydroxy-2,2,4,4-tetramethyl-5-(nitrosomethylidene)imidazolidine
1,2,3,4-tetrahydrocyclopenta[b]indole-7-carboxylic acid
N-METHYL-N-[(1-METHYL-3-PHENYL-1H-PYRAZOL-5-YL)METHYL]AMINE
3-Azabicyclo[3.1.0]hexane-2,4-dione, 1-(4-methylphenyl)-
AZETIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER
2-(PYRIDIN-2-YL)-4,5,6,7-TETRAHYDROOXAZOLO[4,5-C]PYRIDINE
C11H11N3O (201.09020759999999)
2-(2,4-dimethylphenoxy)ethanamine hydrochloride
C10H16ClNO (201.09203559999997)
5-BENZYL-3-METHYL-1,2,4-TRIAZIN-6(1H)-ONE
C11H11N3O (201.09020759999999)
2-methoxy-5-pyridin-4-ylpyridin-3-amine
C11H11N3O (201.09020759999999)
(1R,2R)-2-(methylamino)-1-phenylpropan-1-ol,hydrochloride
C10H16ClNO (201.09203559999997)
8-amino-1,4-dioxaspiro[4.5]decane-8-carboxylic acid
1-(2-(Trifluoromethyl)phenyl)cyclopropanamine hydrochloride
N,N-DIETHYL-2,3,3,3-TETRAFLUOROPROPIONAMIDE
C7H11F4NO (201.07767239999998)
4-(4-Methoxyphenyl)-2-pyrimidinamine
C11H11N3O (201.09020759999999)
3-Amino-6-(aminomethyl)-1,2,4-triazin-5(4H)-one acetate
2-Propenoic acid, 3-(1H-indol-7-yl)-, Methyl ester
4-[(1R)-1-aminobutyl]phenol,hydrochloride
C10H16ClNO (201.09203559999997)
(S)-4-(1-Aminobutyl)phenol hydrochloride
C10H16ClNO (201.09203559999997)
2-METHYL-QUINOLINE-4-CARBOXYLIC ACID HYDRAZIDE
C11H11N3O (201.09020759999999)
[2-(4-methoxy-phenyl)-ethyl]-methyl-amine hydrochloride
C10H16ClNO (201.09203559999997)
2-Amino-5-benzyl-4-hydroxypyrimidine
C11H11N3O (201.09020759999999)
1-(1-ETHOXY-2-PROPYNYL)-1H-BENZOTRIAZOLE
C11H11N3O (201.09020759999999)
3-(2-Methyl-5-Nitroimidazole-1-Yl)-1,2-Propanediol
(Z)-2-Methyl-4-(4-methylbenzylidene)oxazol-5(4H)-one
(3aR,4S,6R,6aS)-2,2-dimethyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxole-6-carboxylate
(R)-3-(4-FLUOROPHENYL)BUTANOICACID
C10H16ClNO (201.09203559999997)
1-(3,4-DIMETHOXYPHENETHYL)-5-OXO-3-PYRROLIDINECARBOXYLICACID
5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinoline-1-carboxylic acid
N,5-DIMETHYL-1-PHENYL-(1H-PYRAZOL-4-YLMETHYL)AMINE
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)ethan-1-one
C11H11N3O (201.09020759999999)
(4-AMINO-6-ANILINO-1,3,5-TRIAZIN-2-YL)ACETONITRILE
C11H11N3O (201.09020759999999)
2-[5-(2-AMINO-ETHYLSULFANYL)-2-METHYL-IMIDAZOL-1-YL]-ETHANOL
C8H15N3OS (201.09357799999998)
2-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopropane-1-carboxylic acid
1H-Imidazole-4-ethanamine,2-(2-methylphenyl)-(9CI)
Pyridine,2-(1,1-dimethylethyl)-5-hydrazinyl-,hydrochloride (1:1)
6-methyl-2-(6-methylpyridin-2-yl)-1H-pyrimidin-4-one
C11H11N3O (201.09020759999999)
3-(4-Methoxyphenyl)-propylamine hydrochloride
C10H16ClNO (201.09203559999997)
4-methyl-6-(3-methylpyrazin-2-yl)pyrimidin-2-amine
N-methyl-1-[1-(3-methylphenyl)pyrazol-4-yl]methanamine,hydrochloride
3-(trideuteriomethyl)imidazo[4,5-f]quinolin-2-amine
C11H7D3N4 (201.10937353399999)
3,5-Dimethyl-1H-pyrazole-1-carboximidamide nitrate
Indanazoline
R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AA - Sympathomimetics, plain C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
1,3,3-Trimethyl-2-(formylmethylene)indoline
(S)-4-Isopropyl-3-propionyl-1,3-oxazolidine-2-thione
2-BROMO-1-(4-(4-METHYL-1H-IMIDAZOL1YL)PHENYL)ETHANONE
1-( 2,3-dihydroxypropyl ) -2-Methyl-5-nitroiMidazole
5-(4-Methoxyphenyl)pyrimidin-2-amine
C11H11N3O (201.09020759999999)
4(3H)-Pyrimidinone, 6-(methylamino)-2-phenyl-
C11H11N3O (201.09020759999999)
(3S)-4,4,4-TRIFLUORO-1-(4-METHYLBENZENESULFONATE)-1,3-BUTANEDIOL
tert-Butyl 4-hydroxy-2-oxopyrrolidine-1-carboxylate
1H-Indene-2-carbonyl chloride, 2-aminooctahydro- (9CI)
C10H16ClNO (201.09203559999997)
Benzenamine, 3-methyl-4-(pyrazinyloxy)- (9CI)
C11H11N3O (201.09020759999999)
Benzenamine, 3-methyl-4-(5-pyrimidinyloxy)- (9CI)
C11H11N3O (201.09020759999999)
Benzenamine, 3-methyl-4-(3-pyridazinyloxy)- (9CI)
C11H11N3O (201.09020759999999)
Pyrrolidine,1-[1-thioxo-2-(trimethylsilyl)ethyl]- (9CI)
N-methyl-1-[3-(1-methylpyrazol-3-yl)phenyl]methanamine
N-METHYL-4-(1H-PYRAZOL-1-YLMETHYL)BENZYLAMINE
1H,3H-Oxazolo[3,4-a]indol-1-one,3,3-dimethyl-(9CI)
1-(2-CHLOROPHENYL)-N-METHYL-N-(1-METHYLPROPYL)-3-ISOQUINOLINECARBOXAMIDE
2-Naphthalenemethanamine, 6-methoxy-a-methyl-, (aR)-
1-(4-methylphenyl)-2-(1h-1,2,4-triazole-1-yl)-ethanone
C11H11N3O (201.09020759999999)
(2-Azidoethoxy)(tert-butyl)dimethylsilane
C8H19N3OSi (201.12973239999997)
(rac)-Aziridine-1,2-dicarboxylic acid 1-tertbutyl ester 2-methyl ester
1H-Indole, 1-(chloroacetyl)octahydro- (9CI)
C10H16ClNO (201.09203559999997)
1-Methyl-3-(2-oxopropylidene)indolin-2-one
D020011 - Protective Agents > D016587 - Antimutagenic Agents D000074385 - Food Ingredients > D005503 - Food Additives D010592 - Pharmaceutic Aids > D005421 - Flavoring Agents D000970 - Antineoplastic Agents
(E)-4,5-Dihydro-6-(2-(4-pyridinyl)ethenyl)-3(2H)-pyridazinone
C11H11N3O (201.09020759999999)
2,4-dimethyl-3-nitroso-1H-1,5-benzodiazepine
C11H11N3O (201.09020759999999)
N-Cyclohexylidene-2-methylpropane-2-sulfinamide
C10H19NOS (201.11872839999998)
5-((Bis(methylamino)methylene)amino)-2-oxopentanoic acid
2-Piperidinecarboxylic acid, trimethylsilyl ester
C9H19NO2Si (201.11849940000002)
Misonidazole
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D011838 - Radiation-Sensitizing Agents D000970 - Antineoplastic Agents
(2S)-3-{[(2E)-4-amino-4-oxobut-2-enoyl]amino}-2-azaniumylpropanoate
3-[(1R,2S,5R,6S)-5-hydroxy-7-oxabicyclo[4.1.0]hept-2-yl]-L-alanine
(2-Imino-3-methyl-5-oxoimidazolidin-4-yl) 2-hydroxypropanoate
1-Cyano-8-(methylsulfinyl)octane
C10H19NOS (201.11872839999998)
A member of the class of aliphatic nitriles that is nonanenitrile in which one of the methyl hydrogens at position 9 has been replaced by a methylsulfinyl group.
2-[(2R,3R,6R)-3-amino-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
2-[(2R,3S,6S)-3-amino-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
hydron;(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol;chloride
C10H16ClNO (201.09203559999997)
5-[[Amino(dimethylazaniumylidene)methyl]amino]-2-oxopentanoate
5-[[Methylamino(methylazaniumylidene)methyl]amino]-2-oxopentanoate
3-Butenamide, N,N-dimethyl-3-(trimethylsiloxy)-
C9H19NO2Si (201.11849940000002)
1-[(4-Amino-2-methylpyrimidin-5-yl)methyl]pyridinium
pseudoephedrine hydrochloride
C10H15NO.HCl (201.09203559999997)
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents A hydrochloride that is the monohydrochloride salt of pseudoephedrine. D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents
1,2-Dihydro-1,1-dimethyl-2-oxo-4,4-bipyridinium(1+)
3-amino-5-morpholinomethyl-2-oxazolidinone
A member of the class of oxazolidinones that is 3-amino-1,3-oxazolidin-2-one substituted by a morpholin-4-ylmethyl group at position 5. It is the metabolite of furaltadone, a broad-spectrum antibacterial drug which was widely used as an additive in livestock and aquaculture feed.
N(3)-fumaramoyl-(S)-2,3-diaminopropanoic acid
An L-alanine derivative obtained by formal condensation of the carboxy group of fumaric acid monoamide with the side-chain amino group of 3-amino-L-alanine.
N(3)-fumaramoyl-(S)-2,3-diaminopropanoic acid zwitterion
An L-alpha-amino acid zwitterion that results from the transfer of a proton from the carboxylic acid group to the alpha-amino group of N(3)-fumaramoyl-(S)-2,3-diaminopropanoic acid; major species at pH 7.3.
L-dihydroanticapsin zwitterion
An L-alpha-amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of L-dihydroanticapsin; major species at pH 7.3.
Terbutylazine-desethyl
A diamino-1,3,5-triazine that is 1,3,5-triazine-2,4-diamine substituted by a tert-butyl group at the amino nitrogen and a chloro group at position 6. It is metabolite of the herbicide terbutylazine.